| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/15/2006 | EP1608634A4 Methods for isolating crystalline form i of 5-azacytidine |
| 03/15/2006 | EP1466014A4 Chemical and biological hazard sensor system and methods thereof |
| 03/15/2006 | CN1746169A Preparation of 4-amino-1-(2-methylol-1,3-oxapentane-5-group)-2(1H)-pyrimidone |
| 03/14/2006 | US7012141 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor nad acceptor dyes linked together |
| 03/14/2006 | US7011943 Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences |
| 03/14/2006 | CA2375430C C-pyrazole a2a receptor agonists |
| 03/14/2006 | CA2295515C Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof |
| 03/09/2006 | WO2006026656A1 Cytotoxic nucleoside analog compound 003 for treating cancer |
| 03/09/2006 | US20060052333 Method of treating arrhythmias |
| 03/09/2006 | US20060052332 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 03/09/2006 | US20060052331 2-Substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity |
| 03/09/2006 | US20060052330 Using a adenosine compound for therapy of tachycardia, angina, myocardial infraction, cardiovascular disorders |
| 03/09/2006 | US20060051791 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/09/2006 | US20060051768 DNA markers for management of cancer |
| 03/09/2006 | CA2578743A1 Partial and full agonists of a1 adenosine receptors |
| 03/08/2006 | EP1141409B1 A kit and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 03/08/2006 | EP1110554B1 Medicinal compositions for treating eye diseases |
| 03/08/2006 | EP1060639B1 Compliant hearing aid and method of manufacture |
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | CN1744903A Process for the production of 2'-branched nucleosides |
| 03/08/2006 | CN1244590C Method for preparing purine derivative disodium nucleotate crystal and dealcoholing method |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/02/2006 | WO2006023272A1 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
| 03/02/2006 | WO2006022323A1 Phosphoramidite compound and method for producing oligo-rna |
| 03/02/2006 | WO2005026184A9 Synthesis and compositions of 2'-terminator nucleotides |
| 03/02/2006 | WO2004046331A3 2’-branched nucleosides and flaviviridae mutation |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | CA2577922A1 Phosphoramidite compound and method for producing oligo-rna |
| 03/02/2006 | CA2577526A1 Antiviral 4'-azido-nucleosides |
| 03/01/2006 | CN1742018A Antiviral nucleoside derivatives |
| 03/01/2006 | CN1243833C Method for preparing guanosines compounds and its intermidiates |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005425 Administering a minimal dose of an Al adenosine receptor agonist in conjunction with a minimal dose of a beta blocker, calcium channel blocker, or cardiac glycoside |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/23/2006 | US20060040890 4-Amino-1-((2R,3S,4S,5R)-5-azido-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one; hepatitis C virus. |
| 02/23/2006 | US20060040889 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| 02/23/2006 | US20060040888 2-propynyl adenosine analogs with modifed 5'-ribose groups having A2A agonist activity |
| 02/23/2006 | CA2575737A1 Tanaproget derivatives, metabolites, and uses thereof |
| 02/22/2006 | EP1627070A1 Xyloglucan conjugates useful for modifying cellulosic textiles |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1243009C Technique for preparing 5'nucleotide bi-sodium |
| 02/22/2006 | CN1242999C Benzo-isoselenazole derivatives and its use |
| 02/21/2006 | US7002006 reacting a nucleoside with a protecting reagent and activator to produce a regioselectively protected oligonucleoside; lutidine activator improves selectivity; for automatic synthesis of primers, probes and antiseisure agents |
| 02/21/2006 | US7001999 tumor antigens for diagnosis/ treatment of melanomas, sarcomas and carcinomas |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001906 Pyrrolo (2,3-B) pyridine derivatives containing Pyran ring, useful as anticancer compounds |
| 02/21/2006 | US7001725 Assay for the detection of preferential particles |
| 02/21/2006 | US7001724 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| 02/21/2006 | CA2309340C Pyrimidine derivatives for labeled binding partners |
| 02/21/2006 | CA2110401C Method for the selection of genetically transformed cells and compounds for use in the method |
| 02/16/2006 | WO2006017052A1 Process for the preparation of a1 adenosine receptor agonists |
| 02/16/2006 | US20060036028 Solid phase synthesis using a solid support prepared by polymerization of a polyarylmethyl-protected alkoxylated styrene monomer that has 2-10 oxyalkylene units |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | CA2573682A1 Process for the preparation of a1 adenosine receptor agonists |
| 02/15/2006 | EP1625139A2 Methods for preparing 2-alkynyladenosine derivatives |
| 02/15/2006 | EP1625138A2 Protected monomers |
| 02/15/2006 | EP1268493B1 Phosphoramidate prodrugs |
| 02/15/2006 | CN1241932C Novel oligosaccharides, preparation method and pharmaceutical composition containing same |
| 02/15/2006 | CN1241925C New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
| 02/15/2006 | CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 02/14/2006 | US6998484 Nucleophile-induced intramolecular ring closure of the C-branched carbohydrate; higher overall yield |
| 02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
| 02/14/2006 | CA2130618C Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates |
| 02/09/2006 | WO2006015357A2 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 02/09/2006 | WO2006014387A1 Synthesis of protected 3’-amino nucleoside monomers |
| 02/09/2006 | WO2005111053A3 Pharmaceutical compositions having anti-inflammatory activity |
| 02/09/2006 | US20060029936 UV excitable energy transfer reagents |
| 02/09/2006 | CA2576826A1 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 02/09/2006 | CA2571601A1 Synthesis of protected 3'-amino nucleoside monomers |
| 02/08/2006 | EP1623223A2 Fluorescently tagged ligands |
| 02/08/2006 | EP1623039A2 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 02/08/2006 | CN1732181A Nucleotide derivatives and DNA microarray |
| 02/08/2006 | CN1240706C Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 02/08/2006 | CN1240386C Matrix metal proteinase and tumor necrosis inhibitor |
| 02/08/2006 | CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole |
| 02/07/2006 | US6995259 efficient solid phase synthesis using a dimethoxytrityl (DMT) protected nucleoside succinate such as 5'-O-DMT-3'-O-succinyl uridine linked to a solid support such as controlled pore glass |
| 02/07/2006 | US6995148 Hypotensive agents, vasodilation, antiischemic agents, cardiovascular disorders |
| 02/07/2006 | US6994998 substituting a base-modified nucleotide that renders the polynucleotide more susceptible to cleavage at the sites of its incorporation for a natural nucleotide in a polynucleotide; 1-ribose-4-amino-5-hydroxy-1,2-dihydropyrimidin-2-one for example |
| 02/07/2006 | CA2375040C Orally active a1 adenosine receptor agonists |
| 02/07/2006 | CA2292754C Process for the preparation of a deoxyuridine derivative |
| 02/02/2006 | WO2005111056B1 New esters of adenosine nucleosides and carboxylic acid |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025375 2'-deoxy- beta -L-erythro-pentofuranonucleosides to those already infected with hepatits B; can be coadministered with 3TC, FTC, L-FMAU, DAPD, famciclovir, penciclovir, BMS-200475, adefovir, lobucavir, ganciclovir, or ribavarin |
| 02/02/2006 | US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024659 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 02/02/2006 | DE10258008B4 Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 02/02/2006 | CA2735079A1 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 02/02/2006 | CA2574651A1 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 02/02/2006 | CA2571079A1 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 02/01/2006 | EP1621077A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/01/2006 | EP1620451A2 Industrially scalable nucleoside synthesis |
| 02/01/2006 | EP1620450A2 Polymeric oligonucleotide prodrugs |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | CN1729297A Deoxyribonucleotides manufacturing by enzymatic reduction of ribonucleotides |
| 02/01/2006 | CN1727356A Technique of chemical synthesis of producing adenosine |
| 02/01/2006 | CN1239511C Novel pyrazine derivatives or salts thereof, containing the derives or the salts and intermediates for the preparation of both |
| 01/31/2006 | US6992180 Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides |